INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137797, 2758, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb0523031c84dd7cf4ed74f49ac040029ab0527', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137798, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a850303450008a170300e8ee0c0a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137799, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a85030d535345000ca140300ffe30c6c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137800, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a8503034d0353451004a1503000b9f0c9c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137801, 2758, 7.0, 7.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33cf4dd7cf4e5708f05728b4c850a8503034504849ac2c060051b106e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137802, 2758, 300.0, 300.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303630c84dd74fc92f4e050023b604c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137803, 2758, 40.0, 40.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d512834d3b5c850a8503034d0353451004a1603000ac50c6f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137804, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c850a85030d735345000ca15030017070cd1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137805, 2758, 20.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332d03531c84dd7cf4ed74f49ac5408f0d7f70c5348c92ccb4c494d512834d3b5c850a85030d7353450004a1703003c1c0d9e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137806, 2758, 600.0, 600.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303330c84dd74fc92f4e050023d404c5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137807, 2758, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c73c957c8cb2f5148ad484e4d4d51303330c84d5728482d52c8cccb4a4d2ec9cccf0300bc4b0b87', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137808, 2758, 30.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac50284a2c49b5523036c84dd7cfcdcc2b2d4955d048c957c8cb2f5148ad484e4d4d51303432004966e49716690200970a102c', X'789ced5ced73da4613ff576efce1193c3518f0eb433a99c176e2b83131358e279d92d11cd221ae96ee943bc931edf87f7f764f4248202caca47d92860f4d82d8fddddebeddeeeae85f5b8e8a5c4b509f6d75c8d6a9c78543fda9cdc5d60ed98a94874f276118e8ceeeee677ec7fc86542efe8bef2e106b5bd18039160d91a7dd6c1fd69bad7aab79d33cea1c343b7b878de3bdbda3bd7d43cbec904ba181f2afad732698a29ef977c81e0cfbcd34601d72154e981a0a2a423ee232e4f6509c494d5d465e4be5eb0eb9e8ed908bdb1dd2bf22b5a303df7d415a074dfc6baf69fec267bb07fee5f6509c4adf9782dc28ea30f20ef60beca71e9333e9a35156a8477814d291c7f0d3ef1fe1136cf6ce7c980b3997ab5c59dd39ede34744ef3a91175ab01d2edcdcd60ba499a9c86ae728fb579da1800dd7f771d3a8844f8793a178cd950e0920830673df3e90d650f4e843879847bb0e9018d571612b46357388e2fa8ec831a8ab411c3e867fd0904cb80b762048ae4193173d5cb6dd6cd6db474d8343a76009a0bfe70e607c3aacb7da0b721c222112cd65386ca6325cf400f5b600f4b60cb4fedf18f83606de3fcef06ee56d884a3f659e17793ce4daea4badf9c89b5a4ec4ac505abdeb41d7aabd171e7238d67bcdb673ca3e6c82004d72e776d0b9082cfaebf19b0679090ff1196874f66c287e6f7f2c587c102a1634acfe84aaa9705188dc02c6658d118f71334d02bbd0053027d40e99e2e00db7d4e5021c288f9309cba148414f2ece00f5681568ffe26cc1b548adc73da7ee4b074c9e7530146edfe00c0568897ce621d8c566e310847a90820d8554043ecb07d8a3d80d941c81fbdadc217c4c8424f0c066cc01bf47bb815268e83311a20b90da80dd33c560c9d4b09f8eb3ebb840497d6e36478543343cb6272494281d1d8366487b7f022e4c6cd003b7a947b80f2bde335ca3509d23a6f992160f631b1b73e0968fea894586a2eb85c607ea87a988870b24592fcd511a2f3de7f7b3edfc1a8190a8b2daa151f1cdc5d9f60b12614cdc9231e8511b7d102ec6b37cb0b085b5325512cd6be4f48665080175ce9db1ed1a0819e21ccadc72e520e773da1c46a2ae728019619c6b37e9b362fa5c3c8736f973933f37f9f387cb9f55236f317d6c426f137acf0dbdef3e78be8ed32f86d2c6eb375eff2d7bfd0fe49fcba7dcc641bf7d07fd1ead54654859357e219e2818cd7eee88f26226b1350bbd1cebcf2df2993168923d67287e6edfb9d0b662cf7937eb8377b35d6bab9dd7e981a14ca88c4e5fc610072b218e276510894475d222be14689d9f5b8d72c9ca711bedfa974b176fb0bd5a92c33a8224ceb99a6a71a1fa51a360b116e9a10a4019a713c8d68a41566c1fd4f7cb96cfcd151ac0d1da6bec2dc1c7c393c631c92081e88e0417b621bcf5dfbd58413951e0b7e69cea49079e870bee0b5414e424ffc9e8279e2335ebed8c99217f3c2174bb71503f9e899c9b2cb55279fb57382a0299cd902a07beac9485ccd338cae06754f2b4ead379d8bc9f2b9a87a5df9649fd8f9b72bde9142b1c4f81fd5a7b89b0385333f2291deff3a038c3a319f70bcd98d977819c57a191b1872976c7eada51c872b2b47d593f984aec06721acc3a95399c52a970bab70e43ba91a2f11a17912ee8edcb44a82f156f58abf107ee3312d76d8174247e5c35d30ba52d6d28ac560e188e52152fecdb287b2f9d8416f984f4fd48f0705aefda9f22aec0f67dc12248f49c5ab5977bbe5c0870281921f4ebc9d9056e9cf3e105075e50c0acc845b6271497701e3d618c7975b230b46e2fc22e0555be2259981543748ab1ec90d4549fe6e5c19a35e0b7e4c28b45c8c687373ebcb60fff33ceb2e4a21b6ff93ebde5abdb6de9e5dac6707f87e1fe1ff2addfa8c7be15301b07c47d19441e9d7b443a3c53cc1554d853720ddf0ae8073be464282ea91d1aeaf8bdb30ddd8a2b15671abfbfdc7f41a0ae6750c38ef0ed74487ceedded0a1912c56c703526609f4371cd04f548dce4939ab99504dd4ddafe6f0fc53b49a8f347a493a11a7cd451107866fe65661513e64b20f7a6a063cc8001533c948201eeecf150bc6101c86a3f67a5731c9be3571d32600cbe420e271e47549c862c6ab27c2c92725809476ef8b4d204e5c029ab85ac5686f531c9e32254940b87db052e513878f4a87d679dc8871ce51bee4e62e9c056e9cd046e730f5c986a2dc1f542f0783083521346d1253453f72c9943292e239d194491cf139c4c85e64f30387a14f5c0d10488790f98675cdb203b9caef03df819da9779531cd66aee0a0e6b430f9daeb743e8c8913e4737b415f503bd639c0844c39b7e724c469e940e3ef3231b4431c116159e7db3667e2fa781aee731e54e71a66b7b00bb8b771ee1f4f66cecf07128674bd3367ec9bb61a3d0b55f10c7d4c924f2c733dbaae1e17765b7af20f433cf89ae0327bd66d635a3f67a296110fb418e6e0d57ba9928e98fa43d0d65c0a0fc188aaea0c164ead107cce583104a0ea1ebbfc889d090fb0653e10003a09d2b2a222fcbf84acb6042dd223325c5aa1439f1ce5229de5170174af0adcc2d785a7cf27553afeb537c67734df504ca9948e10a43f10b8d30638228ef151c3754a10c6fa6810c4160504bbab760e2b111f2901a1cfb11ce83fe692fca1e248b1a2fc75ae2c8e165ecb5cee5e439710e6595a1cb211738ad9433873fb375395e4a99e32ff09072a898c902262b65caeb2ee7626ba86f466f19fa1c16ba673982a1caf1cdfcb89c37a5ccf1a7de5f0e3027cd216482a61c234b9cdc19fad6324f51bbb5493d9bd4b3493dffb6d4f3ad4576954675e39eff5af7c4d9a14fa10b90ee34dff2516f5cf7f8d8bc5adcafef810bf618780af40bdaef904b681ed40b72fa5b7fffa009c7db83ad183a5587bc575cb01d02ad1ece7e7acc9e50012cd88475ed9824b985287568a630d0958de2273677a8b7431c0699dc5ca1825c3b8adc5de805f1bdb032b3874abd0a189eeb19c0d20f2fd2cb30641c791e71b15742813f53bc725543669fffc9088b4f711c2645490f25c576c2af03c5a843a8926069ec6d715487ad5700e1086a875e4bc08ea16d858638f289072783a793df601804a075180bc845a3d7803e3744055e4b50129b7d3a93a657660f78c72cf92546002272f147ac0ebc67d63174efae6e888ba85413b05aa4934546d045e3280e422ac4a11974e5113a04916051f2b285178508ec38320bf6e803c19b07c97d8ef839a9393939f0b71ef0e544466a1bdf4a9b363c6b32a2e13bcfc9f11c23dc650563a62e65c9b115bbd4427ad52a0a428d7a0f1987c5a702ac81f340d8fb88c79e85f639686aa2f8486a389009488103ef2ade95fe9cd21a607041630dffb1f286f82dcbc7dc602874a46d16009ec776750206fa8e74443d6f8abfd8198ad87cf14c84d4ee31278cbc29c9b22adc2efa1a705c0f45fa91d420d88c15c66616831380e426a1411ffc04224c05532ed04368262f9420263e030599ffc8145f3801692a21ce79dedf5c40c082243581269fea90f980918e7d00ff436b280478390de1d0fad086ba3b1602ac043a537207c23d340246f813a6b96c40bdf704f59c30b33394e91ca231205da2f18d0909e66f4a30eb6406524e64c2ef55838c2903203c693fec5759315969f6b2e4e96a1a0e5923215a1f9a069ff465ac5064bb52aef1f3b802c55f3dccb6b3434e76c8e90e39df32cdcdcce7a686323e1f52d81548e9db1c5601e3962bc8d4a036b3d902800fadf5a4a0c2dc428f34712bc1bcc25030efc1006266b902a0ebe7e2f0c8af00d31b0cba15d48917822aac76daadafe0bc28d53e343a0df22ae00e1e044e259d41cbf70783faa29aaa2e1b78c1d1b46d2e13ac488025eb9b0879c75c33bad48b88ef1ac40544a83f252bf4ea329100c0870ed2e4876a2ae949451f205b527cf982957045777cd3c0dce4454cfc59692790c670b05b81f32df40c9ae316745140aeb9f0ee1c86bc1a9c5cfe54056a09e96dffb4129089edb8c2d4c10ee9fac12911ccfd5a5081ac62e20153581b15abb93c7d26dcc4a7ca3697262bc9403d88c1cac61e4cb85b99b98fc519245b9f2b3ae2c56152aa8619c87de4b9500655d10140e04b7661833275d0a82205443d7c302e5a11e1146b8bd8adc85831ec148b82f759380e766870b27e294ec52d7519763d029a8f6a1edeb5a18d0c9f16a2d4b69a454e2205859ecbd41ab402d049a4ee26d273f00e0094c301b579159801345c12341b4c12a17cea85f009dcbf0adc6f605f2842697cb542c6aff2ec2a48af158500d0c685c3c8a30ad92b79ce898aec2722a1b42a602e975f144a7d0a6d47a40c841f817a71a65005e80d65beb14d84dd81add8b43024dba5a5f248718919cabcb55e2f1e7b5cdb4b3139f1a83f758c48b438a8cacabeded49601e46b7fde9e54a92eaeb97dc7c250f3156294274c902399f8443ea1f7c515e4124c57503c7d972b3f1c0208e94fedc232b2acfa8ea751120e0128fd1575571c4665caed2b760fa791f13be6c16381856d713c968974ea49e8aca00805f5e45eab3c3b9167806ad8b6a668db15b6f83ad219bb09669b54a60aad57b6c53e5e60d4f37b8c915e11f100f47179e6b2199dfc18a393e75e5e64ccea7a5ae67c633e9fd3a4d6a35c547e11528cb4eeff6c4d5b09cfe3c7c7c7c7ff01babff34a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137809, 2758, 18.0, 18.0, 'mg', NULL, NULL, 'Adult', X'789c73cbcc4bcc5148cecf4b4ecd2b294a2cc9cccf5328cec82fcd4951c8cb2f5148ad484e4d4d5130b4c84dd7cff5010087ef1075', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137810, 12024, 325.0, 650.0, 'mg', NULL, NULL, 'Adult', X'789c3336325528c957303335c84d57c82f4accc9a904520a45a9c92560766a596a51a5828942467e6951b14262b1425e6a6a4a6a8a8e425e7e0948636a45325000a8205d3f25b11200fbf01a40', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137811, 12024, 324.0, 324.0, 'mg', NULL, NULL, 'Adult', X'789c333632c94d5748ce482d4f4cca495548cb2f020036550630', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137812, 12024, 81.0, 81.0, 'mg', NULL, 1, 'Adult', X'789cb330cc4d57d0484a4caad454702c2ec82ccacc5348cecfcdcdcf534849cccca954484e2c4ac94c4c5628ca2cce56284a4d294d2ec90449e617a7020075ea1597', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137813, 12024, 325.0, 650.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334aaccb7523036325528c957303335c84d5708f057c82f520808522834d135cb00009d100922', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137814, 12024, 10.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d23534acccb75230345028c957303455c84dd7cf4e5708f057c82f520808522834d135cb0000b78409f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137815, 12024, 80.0, 100.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c45cc410e82301046e1abfc4b4d682858957005177a85b11dda069c890535dcde1017eedffb2ef4a199c6dca3b3a6b1168f588fb10eb46217f23b070e783a734a7bdcae78c99227d0c0f7922786ebccb94dd082ad6f5c8525b1e0608e7fe5b78882374c3c4307782d2a5456f8441279fe0218652bd5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137816, 12024, 1.0, 5.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0b2e29cacf4eb552305428c9573055c84dd7cf4ed74f49ac5408f0070079bb087d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137817, 12024, 90.0, 130.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf32a2d4bcdcbcc49550872b452b034d035343650c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d135cb00004deb0e24', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137818, 780, 0.25, 0.25, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b652c8cccb4a4d2e494cca495528cecf292dc9cccfb35230d03332cd4dd7cff5b156004b9580844c75140c75148c72d3015c7116ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137819, 780, 40.0, 40.0, 'mg', NULL, NULL, 'Adult', X'789c3331c84d070002a50139', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137820, 780, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789cb3553032c84d070004ad0194', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137821, 780, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789cb35530cc4d57482acd4d2d49cccb4c4955b055303550c84d07005ee10777', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137822, 780, 0.5, 1.0, 'mg', 'IV', NULL, 'Adult', X'789c15cc3b0e80201045d1adbc0508410d8bb0d2ca7e1207b5c0e19be8ee85eedee6186d510423fc89658724186dd5d46e5b351687fba18363a5c2489c833c99875681a9204e6ac62535e56e787a6f5f3dc46134dd0b9c70d0f703ddfe1f9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137823, 25911, 30.0, 30.0, 'g', NULL, NULL, 'Adult', X'789c33365048cf55c82f4acc01120a05a9450a45a9c925a5b9005e67083e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137824, 25911, 1.0, 1.0, 'g/kg', 'PO', NULL, 'Pediatric', X'789cb333cccdb752305448d7cf4e5708f057c82f520808522834cb00d17e0081500892', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137825, 3182, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492dd151303230c84d070082a508e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137826, 3182, 200.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333230d0353130c84d5708f057284c49ac0400245304b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137827, 3182, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333130c84d5708f05728b4c80000146f0359', X'789ced586d6fdb3610fe2b843fb580dfe2b66ea00f058c745d86b59991facb5017022d9d24ce14e9915416a5c87fdf51526c53562ac57bcb007f312ceab9e78e77c78714bff54295c5bea029f43cd2fb198c0ca4a0779243af4f7a99e276383166a3bdd1e80fb6867428556cffb1511dad03453710fad458a3c978321d8ccf0667e3c5f8adf766ea8d27c3e9f8fcfced598185c030293422bff56661ca04d346513b560c19b82d5816f906bca59809c3a24cc4942fc57ba9690ce48354a9f6c882ae38983e998cc769bc14d73233a0898c884bea91f92f7d62e4860596e342a6a91464a16808e40a678f4c57ec4e2aca8be8b2d57e80f73864ac1ffbf4e52b3e7126d6c5c32ed25d88ed99dbc3de7fb5ecb330e3c6c79931113bf36f88a6f7a1b0f49988f6471f2c301183d736193863f27b48f39e1bbd753757521b6ac00fa8084039f63bdbf3a46efa9d4414bc4744569fdc3f15da5378bb97bfa4869051a358707401b5ff62e2e74095f6a908fd6cf3d2e178357c35980ea7693c5a3f5ad5b6203f6f2060e8742e3719a787c5992b8805a62627d7f856e052f2c8459fd0f00694060237208c2609bd01b2021044db1f2608152ca59c6893850cf4527ca48129e889627a6d597eb80d1418082d7aa5806a4352c6d77d22a4210a025c8a20427cbfca494a45162143a6400d9b52770d0227d190e7620579c88921ff9669839c6629b6a5a9bd69581397b0c1b81b6b5871a3d6a19a3011a28654f3e10cd34342a6715ae0b86b033fa17e8f17a95d69de5b792fc11a1bcedf32f4d0e18ed8ad5a3bed16ef5bbc6fa7184b850d50e9d9df58a67a073cdf3afd576df444b9bad8a73cd08119e7a0e21cb74a1270aaf5c81e108ef0322b85c3bf06dab0153415f633282633175764531a79cb0266723c0784ca7616a6416751848380adbc1497784a40674233c36e1088b2527ab52707ba49724e6f198ad32251325dc920c78300084651ae205b3ffcbf8454f21c8b87a20629a30d22519e1b9c10af6886954047ab50e2890383db6072f198c2eeee9800aded5faa5402850b1ad220b1355699c268ad62824928a67c297ecc85954354c843e79df4c14d57fb32aee11d49684c7587a34d69e6bb660ef3a3d5ea1070cdd4df9abab1ef8adee530b6033b2cf56e69a73ab0704576db6b1d0476877573d7d0a36d35ae2cfccac2e12bbbb79da5c2b959763abe43a21ff07e8177b8b6aba5c396b685d618ca45d685a042d6325b2ecd2e19ad908efdc3826eb7df226bdd51ca4097dea890e55efb2c75b32eee27e13c09e749384fc2f99c84f3dfd5a463ee944e4df6bf6fb2393ea434905ce290b345531e0d388bc023e724598a4f80ed2039d3a9473e169f782f2e7e9dbf7e337eb914e5154a718d1941009abc2318a438e6ebef13040915e8c597913f0b0e2e5c7f12095b31a389ce854940b3e2323500ce490ae94aa11612fc4094da80924fbc2cad8e2be0cfb896ee57e7f64214d750793d46f66e11fff2956ca7dd6c07764adf18cef7b90eef41b119eeefff045cec04f4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137828, 3182, 3.3, 6.6, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d633d635d333cb4dd7cf4e5708f057284c49ac0400351705bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137829, 11398, 500.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c0bc9a82ccacf4c51282ec92fcab552303530d035343030c84d5708f057c8c94f4cc9cc4b5748c92f4ed55148cbcfc9c92f4f4d5148aa543032852a2934c90000eaa5158c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137830, 11398, 50.0, 300.0, 'mg', 'PO', 3, 'Adult', X'789cf3cccb2cc94cccb1523035d0353630c84d5708f05708f17451d0484a2c4e4d51c8cf53284e2d4b2dca2ca9d404002aec0de6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137831, 11398, 50.0, 50.0, 'mg', 'PO', 3, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb5523035c84d5708f05708f1740100694507b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137832, 11398, 50.0, 50.0, 'mg', 'PO', 1, 'Pediatric', X'789cb333abccb752303550c84d5708f0574849cccca9d451484e2c4a4d2bcdc9a954282d28c92c294a2c494d01001a5e0e7b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137833, 4432, 15.0, 25.0, 'mg/kg', 'PO', 1, 'Adult', X'789c3334d5353255c84dd7cf4e5708f0574849cccca954d0c8cc5348cecf4dcacc4b2cc9cccf5328cf2cc950c82fc9482d52484c4fcd2b29d60400e371129d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137834, 4432, 15.0, 25.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3334d53532cd4dd7cf4e5708f0574849cccca90400333905c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137835, 4796, 40.0, 160.0, 'mg', 'PO', 1, 'Adult', X'789c3331d0353433c84d5708f0574849cccca90400261604ef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137836, 4005, 37.5, 225.0, 'mg', 'PO', 1, 'Adult', X'789c73ad2849cd4b494d51284acd494d2c4eb5523036d733d5353232cd4d5708f0574849cccca90400eb820be6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137837, 4005, 75.0, 375.0, 'mg', 'PO', 1, 'Adult', X'789cf3cccd4d4dc94c2c4955284acd494d2c4eb5523037d5353637cd4d5708f0574849cccca954c8cc5330d2355648c92ccb4c494d5148c92f4e2d060022ad12c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137838, 527, 7.5, 7.5, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d733cd4dd7cf4e57f0f4d5f70c53283434ca000034c40550', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137839, 527, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c33cd4dd7cf4e57f0f4d5f70c5328b4c8000028ca04c0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137840, 527, 250.0, 250.0, 'mg', 'IM', 2, 'Adult', X'789c333235c84d57f0f45570f274010013cb0311', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137841, 527, 10.0, 10.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334c84dd7cf4e57f0f4d5f70c53a850305408f170f50300463e05f3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137842, 527, 7.5, 7.5, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d733cd4dd7cf4e57f0f4d5f70c53283434ca000034c40550', X'789ced586b4f233916fd2b56be2ca326cf868689e64b087483ba612202a8479316725c37556e5c768deda2a91df57fdfe3ca830045076a34a39576bfa52af6f17d9c7bee75fdd9886c1e5f6b9e52a3cf1a8354de702175639b3572abc2abc4fbccf5dbed6ff286d296b171f825dbeb2b9db03ca3e89afbb0a1d7e9bd6b76bacd6ee7a2b3d7dfd9ebf7765bbb7beff677df966b497869b4c3ca3f1b1f4893e5aafcede9aedc7e5164d49f68e06b13ab421827239ae843e3784cecbdb1a9eb33a9bf02874f153167541e1027fadce49e1c33333688b05b3a6f79f8a7cf4e4eb7d9c9d5440f4d9a1acd2e2c8f889dc167400547166ee4d375ebbee355794478fafd0b9e94d437e5c3bdb50fcd7c51d8d6d77fff124e1944b9f2d7f050eaf8412c0eb8f06425577078b6306da2f75abb69dcbe89e156fbe48afdd1ed2513fdebf9443f7cbd8fb7975a98345352704f11bbbc3899e8de6e270d6bd8c1c9e1ebbc2e6d1d5124b9b75254d97b4646e32487fc753bebc6dcb12ebb383e3a7bc6f8133de3da3bd666c344aac8927eea0c3b1d7c66ddd62e8bdb112f6a583ece482094d72393e58adf937069fcc852acb916053bc7bf3a9e80388713fd093958d068cc67e40b76a96fb4f91608471aa999c7018c0d5904c7ec50b1dd4e73bfc362794bc1c3666f2759fcd1ed3477977ff4769a3bfbcb3f7ee92e5fefec37f742508e0ffbf3372ecf32452969a0afc2bfd8f6760d0f0775f7d70eeafdbcfc637fcd82aa83daa343e63cb79e2da28e7c6d336d1e1c7d4c19e22016feb233e3d921cda4a6a86ef13c8ef8e6f2390c62355fecaea5be5e212c2a6968348a5eea2830fe4986074a918d0be60d138a3bd70eda578349435e2aceb59cf51fe027902eeb483be943807d889f9a4914c444db922b32cdb8b4f378469414d15ca12628532d728b459e69ca126bbcb943ac217978933b08e07c2baa98e791f4c616ed5b725e4ec165cb66b9164f808051a2b435e51580e5db3477a24488a4231e5e934224ac518527c6a71a7acb15fc412c5e1fa841741b02727d4e5c3c4d470560630cb933b97ba42aab80485f40eafcdac3d9cab7fbc795535365c40d0fed639c23352b116d3cb47bce9cd01a1e9c7ba4e8b6c50e2ecf822ed95000dc06e62be3825481845afa1cb9bd22eb656c828e7d9d1fc040016276e1f6e3e3362ad53f1684c7e1ff6f8ac2df6dcb6b1b5fc2510ac22813170f8c3ae66ad65472467dd64bd8161479ff1d4bd0b1d9e39aff69a24f096718255dda87826a24e5e84e589af7974b3843618d4838c697b41c65c4fcbfc5282064c4d5369b42e25c1098b79d31b3726a9c4199426ea63922b08dc3133995e8a819784130c515da27e4a46bd529630d9d9106e27f3d5ea8db5c113655f3477a18aaf1443bd09232e0296adf4be556ee72ae5481086144911aaea665a7c35fb7c8318c2bd8fa561b7cf1bc8ce97950d7c523db32168dcb339a953407b68033680773f4f11b985060ea8cb11e7af84dfa8409528a7dc30ac6579e82449758bab270065ccc4fcc6858b2a503a10ae72905c6aaa280ffb90b61352ce29ee3a137d17c6e045280985983d4e5be34101a1cadd986d56f7fb0fa7ee19a67c1a60fd6e4191ba07d5bca580692163a86c99883eddad4c8a2bc6c48472d36e3042009073fefd439717112da07ca53f21f9735ba7d6961c8fe07cb533632f380866dbfdab8e479498d80da5abab3cd0eb6d9709b7d689472b8e45c6053e3bc8123d6609f411a2d0da41a1857d2a2d010b6d2d90a80cfdd9759c1910c6dc05c16d782390aa56084110210cbcc55008d5f8b23f3b4465c4ec7e3418dd34fcf2bb76d3a6d38683eb3f305e1e759d26247196e5936955165d04e369ddf625f090368bd587d6a31f0cf88c21b0c5df492ac95157246310f15e21e039eb5580c406b1343b5580d00b42159ea43754436e6df587e07b5e40cf335872535e978dc0adaa472d2ffaef464239d5b0c9d58d6d8f951d1d4c9e082ab2ac8171edcbe876147e3834f6fea403d41fa381a56016d4acabcb6a7e580e0b26d3648b3216e11716d99780495993a29c6101b2e37d561de5cbf8bdd2ce55610fabeae65035728c16793bdd98a44c6b5a9320aa317d43695964f65759d6cb46009729bab1873509d2000e2162aa805a2e9b2561d2b50f67828395a136118868b39afd8cc528e1b7a55f5be0a2792e17699d78aeb3a4e4d9706a814b08b6348a845ae81c0b4ef7f6cc4a60e357294470b2b38d9bc1c36780d921ce4f626312a0a5f1b310f675cc82a98cdb3176176b4264b1646e156e2f104fad781fb0df9c514ca192dc697f02542d4f1efbde528005752d8876b71d85ea79a0e6c2e7e5008e337ffda3416502ccd5faaa511c7c523b725449a23bee1525807e898535a26270ff7035c438b5a357925a7569a20515acea4a82cc8c7443e954e3ca9c944f1b4884a8b7875516d9c4f0a6132e8757a7f3fa933289d4b7143de3bf917cc98d7354647c66fab07c8c7541b681e9aefd3c12f7c03d0262d44e510b9c998f99703831680c9dff2f89956b4096664e916bda8241d29bcd661acadaec68d83bd32b8586106457422390369a4aa93a7759cad70695d81fd5487c8ef73b796364da214325b6bfa1f51e64d797bf4cb6b5775b903e8cbd34f2effff72f2bff1e5e4355fe2be7fff0fa5ead194', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137843, 527, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33cd4dd7cf4e57f0f4d5f70c5328b4c850f0758c5030d4335548d74f49ac04008389086e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137844, 12802, 40.0, 80.0, 'mg', 'PO', 2, 'Adult', X'789cf34dcccb4cd42f28ae4ccec82fce2cb65230315028c957b03050c84d5708f05770f2740100d72c0ae6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137845, 12802, 10.0, 20.0, 'mg', 'IM', 1, 'Adult', X'789c734c2e2d4955484ccf2c492cc9cccfb3523034d03532c84d57f0f4552834d235c9d05130017173132b14521233732a0185030f50', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137846, 12802, 20.0, 80.0, 'mg', NULL, 2, 'Pediatric', X'789c734c4f553034d03534b75228cec92fcfa95428c92c294a2c4955282d5028c95728492c4a4f2d5148c92f4e553032d0b530c84d5770f2740100f0a81199', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);